1. Home
  2. AMRX vs HAYW Comparison

AMRX vs HAYW Comparison

Compare AMRX & HAYW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMRX
  • HAYW
  • Stock Information
  • Founded
  • AMRX 2002
  • HAYW 1925
  • Country
  • AMRX United States
  • HAYW United States
  • Employees
  • AMRX N/A
  • HAYW N/A
  • Industry
  • AMRX Biotechnology: Pharmaceutical Preparations
  • HAYW Electronic Components
  • Sector
  • AMRX Health Care
  • HAYW Technology
  • Exchange
  • AMRX Nasdaq
  • HAYW Nasdaq
  • Market Cap
  • AMRX 2.4B
  • HAYW 2.6B
  • IPO Year
  • AMRX N/A
  • HAYW 2021
  • Fundamental
  • Price
  • AMRX $7.41
  • HAYW $14.18
  • Analyst Decision
  • AMRX Strong Buy
  • HAYW Hold
  • Analyst Count
  • AMRX 5
  • HAYW 5
  • Target Price
  • AMRX $10.80
  • HAYW $16.83
  • AVG Volume (30 Days)
  • AMRX 2.1M
  • HAYW 1.8M
  • Earning Date
  • AMRX 05-02-2025
  • HAYW 05-01-2025
  • Dividend Yield
  • AMRX N/A
  • HAYW N/A
  • EPS Growth
  • AMRX N/A
  • HAYW 51.32
  • EPS
  • AMRX N/A
  • HAYW 0.56
  • Revenue
  • AMRX $2,830,186,000.00
  • HAYW $1,067,878,000.00
  • Revenue This Year
  • AMRX $10.49
  • HAYW $4.98
  • Revenue Next Year
  • AMRX $7.00
  • HAYW $5.89
  • P/E Ratio
  • AMRX N/A
  • HAYW $25.10
  • Revenue Growth
  • AMRX 13.42
  • HAYW 7.34
  • 52 Week Low
  • AMRX $5.18
  • HAYW $11.10
  • 52 Week High
  • AMRX $9.48
  • HAYW $16.87
  • Technical
  • Relative Strength Index (RSI)
  • AMRX 46.13
  • HAYW 62.85
  • Support Level
  • AMRX $7.15
  • HAYW $13.65
  • Resistance Level
  • AMRX $8.02
  • HAYW $14.28
  • Average True Range (ATR)
  • AMRX 0.32
  • HAYW 0.40
  • MACD
  • AMRX 0.02
  • HAYW 0.19
  • Stochastic Oscillator
  • AMRX 31.07
  • HAYW 94.85

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a global pharmaceutical company operating primarily in the U.S., India, and Ireland. With three reportable segments; Generics, Specialty, and AvKARE - It develop, manufacture, and distribute a diverse portfolio of essential medicines. The Generics segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

About HAYW Hayward Holdings Inc.

Hayward Holdings is a leading manufacturer of energy-efficient swimming pool equipment and pool automation systems. The company offers a wide range of pool equipment, including pumps, filters, heaters, LED lights, and sanitization. Headquartered in Charlotte, North Carolina, the company has around 2,000 full-time employees. Hayward generated approximately $1.1 billion in revenue in 2024.

Share on Social Networks: